US Stock MarketDetailed Quotes
FNCH Finch Therapeutics
- 2.2400
- -0.1200-5.08%
Close Apr 19 16:00 ET
- 2.1700
- -0.0700-3.13%
Post 19:24 ET
3.60MMarket Cap-48P/E (TTM)
2.2900High2.1600Low29.87KVolume2.2900Open2.3600Pre Close65.92KTurnover3.77%Turnover RatioLossP/E (Static)1.61MShares16.740052wk High0.16P/B1.78MFloat Cap1.860052wk Low--Dividend TTM792.86KShs Float675.0000Historical High--Div YieldTTM5.51%Amplitude1.8600Historical Low2.2060Avg Price1Lot Size
Finch Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -87.57%107K | 0 | 0 | 0 | -69.77%107K | -95.35%861K | -99.01%8K | -98.78%138K | -87.24%361K | -90.04%354K |
| Operating revenue | -87.57%107K | --0 | --0 | --0 | -69.77%107K | -95.35%861K | -99.01%8K | -98.78%138K | -87.24%361K | -90.04%354K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -61.70%34.11M | -77.27%4.68M | -82.58%3.74M | -58.89%9.08M | -26.99%18.21M | 13.42%89.06M | 3.64%20.59M | 0.78%21.44M | 11.29%22.09M | 42.26%24.93M |
| Selling and administrative expenses | -25.65%26.91M | -48.22%4.68M | -61.03%3.74M | 8.73%8.88M | 2.26%9.62M | 70.41%36.19M | 78.48%9.04M | 67.00%9.58M | 38.80%8.16M | 106.59%9.4M |
| -General and administrative expense | -25.65%26.91M | -48.22%4.68M | -61.03%3.74M | 8.73%8.88M | 2.26%9.62M | 70.41%36.19M | 78.48%9.04M | 67.00%9.58M | 38.80%8.16M | 106.59%9.4M |
| Research and development costs | -86.38%7.2M | --0 | --0 | -98.54%203K | -44.70%8.59M | -7.71%52.86M | -21.97%11.55M | -23.67%11.86M | -0.29%13.92M | 19.69%15.53M |
| Operating profit | 61.45%-34M | 77.26%-4.68M | 82.47%-3.74M | 58.21%-9.08M | 26.37%-18.1M | -47.03%-88.19M | -7.98%-20.58M | -114.49%-21.31M | -27.68%-21.73M | -75.90%-24.58M |
| Net non-operating interest income expense | 523.02%1.57M | 28.57%333K | 771.11%392K | 746.15%420K | 3,169.23%425K | 1,045.45%252K | 3,137.50%259K | 462.50%45K | -1,028.57%-65K | 1,400.00%13K |
| Non-operating interest income | 523.02%1.57M | ---- | ---- | ---- | 3,169.23%425K | 1,045.45%252K | ---- | ---- | ---- | --13K |
| Total other finance cost | ---- | ---- | -771.11%-392K | -746.15%-420K | ---- | ---- | ---- | -462.50%-45K | 1,028.57%65K | ---- |
| Other net income (expense) | -71.45%-45.78M | 119.55%1.31M | 104.85%927K | 288.12%1.71M | -49.73M | -1,581.09%-26.7M | -668,300.00%-6.68M | -63,603.33%-19.11M | -149.40%-909K | |
| Special income (charges) | -81.84%-49.84M | 104.28%307K | 99.65%-68K | 177.56%705K | ---50.78M | -1,577.41%-27.41M | ---7.17M | ---19.33M | -149.00%-909K | --0 |
| -Less：Restructuring and merger&acquisition | 58.03%3.82M | -209.05%-265K | -96.38%46K | -11.30%801K | --3.24M | --2.42M | --243K | --1.27M | --903K | --0 |
| -Less:Impairment of capital assets | 84.29%46.04M | --0 | --0 | --0 | --46.04M | --24.98M | --6.93M | --18.06M | --0 | --0 |
| -Less:Other special charges | --614K | --0 | ---- | ---752K | --1.37M | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | 9,200.00%637K | 4,300.00%42K | ---22K | 12,666.67%754K | ---137K | -125.00%-7K | ---1K | --0 | -121.43%-6K | --0 |
| Other non- operating income (expenses) | 477.35%4.05M | 105.76%1M | 360.65%995K | --1.01M | --1.05M | 1,450.00%702K | 48,700.00%486K | 820.00%216K | ---- | ---- |
| Income before tax | 31.78%-78.22M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -174.35%-67.4M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M | -49.65%-22.7M | -75.72%-24.57M |
| Income tax | -3.46M | 0 | 0 | 0 | -3.46M | 0 | 0 | 0 | 0 | 0 |
| Net income | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -160.26%-63.94M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M | -49.65%-22.7M | -75.72%-24.57M |
| Net income continuous Operations | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -160.26%-63.94M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M | -49.65%-22.7M | -75.72%-24.57M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -160.26%-63.94M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M | -49.65%-22.7M | -75.72%-24.57M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 69.38%-6.95M | -160.26%-63.94M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M | -49.65%-22.7M | -75.72%-24.57M |
| Basic earnings per share | 35.40%-46.59 | 88.75%-1.89 | 94.05%-1.51 | 69.74%-4.33 | -155.77%-39.9 | -62.43%-72.12 | -40.00%-16.8 | -302.86%-25.38 | -49.06%-14.31 | 48.00%-15.6 |
| Diluted earnings per share | 35.40%-46.59 | 88.75%-1.89 | 94.05%-1.51 | 69.74%-4.33 | -155.77%-39.9 | -62.43%-72.12 | -40.00%-16.8 | -302.86%-25.38 | -49.06%-14.31 | 48.00%-15.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg